Cordant Inc’s Seagen Inc. Common Stock SGEN Stock Holding History

Cordant Inc’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15	Closed	-$2K	–	1354
2022 Q1	$2K	Buy	+15	New	+$2.03K	﹤0.01%	817

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cordant Inc's SGEN Position: Q2 2022 in Review

Cordant Inc sold out of Seagen Inc. Common Stock (SGEN) in Q2 2022, closing a stake of 15 shares — an estimated $2K sold.

Cordant Inc first reported a position in SGEN in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 549 funds tracked by Wall St. Rank hold SGEN as of Q2 2022.

Cordant Inc reported no remaining Seagen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 15 Seagen Inc. Common Stock shares in Q2 2022, an estimated $2K.
Cordant Inc first reported a position in Seagen Inc. Common Stock in Q1 2022 and held it in 1 quarter.
Cordant Inc's Seagen Inc. Common Stock position peaked at $2K in Q1 2022.
549 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.